YZ

Yong Zhang

Merck: 8 patents #1,412 of 9,382Top 20%
UC University Of Southern California: 3 patents #277 of 1,826Top 20%
NO Novan: 1 patents #11 of 17Top 65%
SU Shandong Agricultural University: 1 patents #8 of 61Top 15%
Overall (All Time): #337,926 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
11938219 Synthetic extracellular vesicles for novel therapies Xiaojing Shi, Qinqin Cheng 2024-03-26
11932637 Chromane amidine monobactam compounds for the treatment of bacterial infections Helen Chen, Shuzhi Dong, Zhiyong Hu, Jing Su, Tao Yu 2024-03-19
11684676 Site-specific antibody-drug conjugates by ADP-ribosyl cyclases Zhefu Dai, Xiao-Nan Zhang 2023-06-27
11497787 Functionalized poly-ADP-ribose polymers for drug delivery 2022-11-15
11213555 Intravenous injection for enhancing immune function Youfei Shi 2022-01-04
11136378 Methods of curing HBV infection and providing complete protection against HBV infection 2021-10-05
10925689 Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same Ryan Doxey 2021-02-23
10428076 Soluble guanylate cyclase stimulators Raphaelle Berger, Yi-Heng Chen, Guoqing Li, Joie Garfunkle, Hong Li +9 more 2019-10-01
10030027 Soluble guanylate cyclase stimulators Raphaelle Berger, Yi-Heng Chen, Guoqing Li, Joie Garfunkle, Hong Li +9 more 2018-07-24
9783552 Soluble guanylate cyclase activators Xiaoqing Han, Alan Whitehead, Subharekha Raghavan, Timothy A. Cernak, Spencer Dreher +2 more 2017-10-10
9611278 Soluble guanylate cyclase activators Xiaoqing Han, Alan Whitehead, Subharekha Raghavan, Jonathan Groeper, Jian Guo 2017-04-04
7807692 Antidiabetic oxazolidinediones and thiazolidinediones James F. Dropinski, Peter T. Meinke, Guo Q. Shi 2010-10-05
7629372 Compounds for the treatment of dyslipidemia and other lipid disorders James F. Dropinski, Guo Q. Shi 2009-12-08
7524882 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders Guo Q. Shi 2009-04-28